Gara Jalqabaatti › Tumor Rhabdoid
Qorannoo klinikaalii Tumor Rhabdoid Ameerikaa Keessatti hirmaatuu
Qorannoo 17 Tumor Rhabdoid f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Washington, DCQorannoo 5
- Houston, TXQorannoo 4
- St. Louis, MOQorannoo 3
- Mountain View, CAQorannoo 3
- Birmingham, ALQorannoo 3
Naannoon
- AlabamaQorannoo 3
- CaliforniaQorannoo 4
- Distaarikii KoloombiyaaQorannoo 5
- MissouriQorannoo 3
- TennesseeQorannoo 3
- TexasQorannoo 6
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07087002NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 3 hanga 25 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07664176HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Namoota walitti qabaa jiraSadarkaa 1
36 Months – 22 Years · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT03911388B7-H3.CD28Z.CART in CNS Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 2 hanga 21 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07390539Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 26 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06465199Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT04715191C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Namoota walitti qabaa jiraSadarkaa 1
12 Months – 25 Years · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT04099797Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
6 Months – 25 Years · Saalaa hunda · Haaromfame 30-Wax-2026 · NCT06625190Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 1 hanga 39 · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT07447076Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT06193759B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Namoota walitti qabaa jiraSadarkaa 1
Hanga umuriin 21 · Saalaa hunda · Haaromfame 19-Cam-2026 · NCT04897321Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Namoota walitti qabaa jiraSadarkaa 1/2
12 Months – 30 Years · Saalaa hunda · Haaromfame 19-Cam-2026 · NCT04901702A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Namoota walitti qabaa jiraSadarkaa 2
12 Months · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT05985161Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 26 · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT04185038Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 26 · Saalaa hunda · Haaromfame 17-Gur-2026 · NCT07148050Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Namoota walitti qabaa jiraSadarkaa 1
Hanga umuriin 21 · Saalaa hunda · Haaromfame 03-Sad-2025 · NCT06198296A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Namoota walitti qabaa jiraSadarkaa 2
18 Months – 40 Years · Saalaa hunda · Haaromfame 12-Hag-2025 · NCT05135975Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.